July 12, 2016 – By BRAD PERRIELLO   A pair of top officials at the FDA are advocating for a national oversight system for medical devices that would combine pre- and post-market clinical studies with adverse event reporting and electronic health records. FDA commissioner Dr. Robert Califf and Dr. Jeffrey Shuren, head of the agency’s Center for […]